Drugs.com - Pharma Industry News

Monthly News Roundup - February 2025

FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy Izervay (avacincaptad pegol) from Astellas is now FDA-approved without a limitation on duration of dosing, allowing greater flexibility when managing Geographic Atrophy...

Mar 2, 2025 - 23:20
 0
Monthly News Roundup - February 2025
FDA Updates Izervay Label to Lengthen Treatment Duration for Geographic Atrophy Izervay (avacincaptad pegol) from Astellas is now FDA-approved without a limitation on duration of dosing, allowing greater flexibility when managing Geographic Atrophy...
Read More

Tags:

Previous Article

$9 Airport Lounge Reservations: Could The Club’s Skip-The-Line Fee Set A New Sta...

Next Article

Topshop preps for relaunch, teases new website

Related Posts

Low LDL-C Levels Linked to Reduced Risk for Dementia

Low LDL-C Levels Linked to Reduced Risk for Dementia

Apr 9, 2025  0

ADHD Symptoms Linked to Onset of Nicotine, Tobacco Use in Youth

ADHD Symptoms Linked to Onset of Nicotine, Tobacco Use ...

Feb 14, 2025  0

Opioid Rx in the ED Slightly Raises Risk for Future Opioid Use, Hospitalization

Opioid Rx in the ED Slightly Raises Risk for Future Opi...

Feb 10, 2025  0